http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5446773-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-937
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
filingDate 1977-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eeae1b777201c1ca98d195cb4e84ad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc60a4bffa1b41aaa487ae51c1002d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59b72f1da74dc80480bf5c440b9dc994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c30f1dd522a09387a886b20c2c96edd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156db00e2d809bd00983d9dfed3f70f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de40fbf2425cd2e61b9d2230f86fb4b0
publicationDate 1979-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5446773-A
titleOfInvention Prostaglandin i2 analog and its preparation
abstract NEW MATERIAL:Proataglandin analogs of formulaI(Y is ethylene, transvinylene; R 1 is -C n H 2n COOR 5 ; R 5 is 1-4C alkyl; wave lines on the 11, 15 positions mean α-,β-conformation or their mixture; the double bond between the 5 and 6 positions is Z) or their cyclodextrin clathrates. n EXAMPLE: (5Z, 13E)-(9α,11β,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienolic 2-(NN-dethylamino)ethyl ester. n USE: Prostaglandin-like medicines especially suited for remedy and preventive medicines for hypertonia, arteriosclerosis, heart failure and thrombosis. n PREPARATION: A compound of formula III [the absolute conformation at the 5 and 6 positions are (5S,6S)] derived from a compound of formula II (R 10 is H or so) is subjected to dehydrobromination to form the objective compound of formulaI. n COPYRIGHT: (C)1979,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5585578-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07126161-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6215551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010505808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H042595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6013779-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013231038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015134801-A
priorityDate 1977-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325

Total number of triples: 33.